Logo image of FRE.DE

FRESENIUS SE & CO KGAA (FRE.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:FRE - DE0005785604 - Common Stock

48.76 EUR
+0.21 (+0.43%)
Last: 12/23/2025, 7:00:00 PM
Fundamental Rating

4

FRE gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 33 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of FRE get a neutral evaluation. Nothing too spectacular is happening here. FRE is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year FRE was profitable.
FRE had a positive operating cash flow in the past year.
FRE had positive earnings in 4 of the past 5 years.
Each year in the past 5 years FRE had a positive operating cash flow.
FRE.DE Yearly Net Income VS EBIT VS OCF VS FCFFRE.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

1.2 Ratios

With a Return On Assets value of 2.69%, FRE perfoms like the industry average, outperforming 54.55% of the companies in the same industry.
Looking at the Return On Equity, with a value of 6.14%, FRE is in line with its industry, outperforming 45.45% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 3.26%, FRE is doing worse than 66.67% of the companies in the same industry.
FRE had an Average Return On Invested Capital over the past 3 years of 1.83%. This is below the industry average of 6.56%.
The last Return On Invested Capital (3.26%) for FRE is above the 3 year average (1.83%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.69%
ROE 6.14%
ROIC 3.26%
ROA(3y)0.52%
ROA(5y)1.33%
ROE(3y)2%
ROE(5y)5.13%
ROIC(3y)1.83%
ROIC(5y)2.61%
FRE.DE Yearly ROA, ROE, ROICFRE.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10

1.3 Margins

Looking at the Profit Margin, with a value of 5.11%, FRE belongs to the top of the industry, outperforming 90.91% of the companies in the same industry.
FRE's Profit Margin has declined in the last couple of years.
With an excellent Operating Margin value of 9.76%, FRE belongs to the best of the industry, outperforming 87.88% of the companies in the same industry.
In the last couple of years the Operating Margin of FRE has declined.
FRE's Gross Margin of 24.99% is in line compared to the rest of the industry. FRE outperforms 51.52% of its industry peers.
In the last couple of years the Gross Margin of FRE has declined.
Industry RankSector Rank
OM 9.76%
PM (TTM) 5.11%
GM 24.99%
OM growth 3Y-9.84%
OM growth 5Y-8.98%
PM growth 3Y-23.64%
PM growth 5Y-16.51%
GM growth 3Y-3.58%
GM growth 5Y-3.36%
FRE.DE Yearly Profit, Operating, Gross MarginsFRE.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), FRE is destroying value.
Compared to 1 year ago, FRE has about the same amount of shares outstanding.
Compared to 5 years ago, FRE has more shares outstanding
Compared to 1 year ago, FRE has an improved debt to assets ratio.
FRE.DE Yearly Shares OutstandingFRE.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
FRE.DE Yearly Total Debt VS Total AssetsFRE.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

An Altman-Z score of 2.07 indicates that FRE is not a great score, but indicates only limited risk for bankruptcy at the moment.
FRE has a Altman-Z score (2.07) which is in line with its industry peers.
FRE has a debt to FCF ratio of 11.28. This is a negative value and a sign of low solvency as FRE would need 11.28 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 11.28, FRE is in line with its industry, outperforming 45.45% of the companies in the same industry.
A Debt/Equity ratio of 0.61 indicates that FRE is somewhat dependend on debt financing.
The Debt to Equity ratio of FRE (0.61) is better than 78.79% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 11.28
Altman-Z 2.07
ROIC/WACC0.62
WACC5.26%
FRE.DE Yearly LT Debt VS Equity VS FCFFRE.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.3 Liquidity

A Current Ratio of 1.26 indicates that FRE should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.26, FRE is in the better half of the industry, outperforming 60.61% of the companies in the same industry.
FRE has a Quick Ratio of 1.26. This is a bad value and indicates that FRE is not financially healthy enough and could expect problems in meeting its short term obligations.
FRE has a Quick ratio (0.99) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 0.99
FRE.DE Yearly Current Assets VS Current LiabilitesFRE.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 215.74% over the past year.
Measured over the past years, FRE shows a decrease in Earnings Per Share. The EPS has been decreasing by -2.29% on average per year.
Looking at the last year, FRE shows a small growth in Revenue. The Revenue has grown by 2.13% in the last year.
FRE shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -9.22% yearly.
EPS 1Y (TTM)215.74%
EPS 3Y-2.62%
EPS 5Y-2.29%
EPS Q2Q%20.29%
Revenue 1Y (TTM)2.13%
Revenue growth 3Y-16.51%
Revenue growth 5Y-9.22%
Sales Q2Q%2.22%

3.2 Future

FRE is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.63% yearly.
FRE is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.90% yearly.
EPS Next Y15%
EPS Next 2Y12.68%
EPS Next 3Y11.74%
EPS Next 5Y10.63%
Revenue Next Year4.48%
Revenue Next 2Y4.84%
Revenue Next 3Y4.86%
Revenue Next 5Y4.9%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
FRE.DE Yearly Revenue VS EstimatesFRE.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10B 20B 30B 40B
FRE.DE Yearly EPS VS EstimatesFRE.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2 3 4

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 14.30, the valuation of FRE can be described as correct.
Based on the Price/Earnings ratio, FRE is valued a bit cheaper than 66.67% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.57. FRE is valued slightly cheaper when compared to this.
Based on the Price/Forward Earnings ratio of 12.76, the valuation of FRE can be described as correct.
Based on the Price/Forward Earnings ratio, FRE is valued a bit cheaper than 66.67% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of FRE to the average of the S&P500 Index (24.04), we can say FRE is valued slightly cheaper.
Industry RankSector Rank
PE 14.3
Fwd PE 12.76
FRE.DE Price Earnings VS Forward Price EarningsFRE.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

FRE's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. FRE is more expensive than 63.64% of the companies in the same industry.
FRE's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. FRE is more expensive than 66.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF 22.91
EV/EBITDA 10.53
FRE.DE Per share dataFRE.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

FRE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.95
PEG (5Y)N/A
EPS Next 2Y12.68%
EPS Next 3Y11.74%

3

5. Dividend

5.1 Amount

FRE has a Yearly Dividend Yield of 2.05%.
Compared to an average industry Dividend Yield of 1.44, FRE pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.00, FRE has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.05%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
FRE.DE Yearly Dividends per shareFRE.DE Yearly Dividends per shareYearly Dividends per share 2015 2016 2019 2020 2021 2022 2023 2025 0.5 1 1.5

5.3 Sustainability

59.84% of the earnings are spent on dividend by FRE. This is a bit on the high side, but may be sustainable.
DP59.84%
EPS Next 2Y12.68%
EPS Next 3Y11.74%
FRE.DE Yearly Income VS Free CF VS DividendFRE.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B
FRE.DE Dividend Payout.FRE.DE Dividend Payout, showing the Payout Ratio.FRE.DE Dividend Payout.PayoutRetained Earnings

FRESENIUS SE & CO KGAA

FRA:FRE (12/23/2025, 7:00:00 PM)

48.76

+0.21 (+0.43%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-05 2025-11-05/bmo
Earnings (Next)03-25 2026-03-25/amc
Inst Owners46.81%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap27.46B
Revenue(TTM)22.35B
Net Income(TTM)1.14B
Analysts86.09
Price Target55.3 (13.41%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.05%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP59.84%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.22%
Min EPS beat(2)8.91%
Max EPS beat(2)13.53%
EPS beat(4)4
Avg EPS beat(4)13.17%
Min EPS beat(4)8.91%
Max EPS beat(4)17.61%
EPS beat(8)5
Avg EPS beat(8)-25.39%
EPS beat(12)7
Avg EPS beat(12)-39.44%
EPS beat(16)8
Avg EPS beat(16)-31.03%
Revenue beat(2)1
Avg Revenue beat(2)-1.68%
Min Revenue beat(2)-4.68%
Max Revenue beat(2)1.31%
Revenue beat(4)3
Avg Revenue beat(4)0.47%
Min Revenue beat(4)-4.68%
Max Revenue beat(4)2.84%
Revenue beat(8)4
Avg Revenue beat(8)-0.27%
Revenue beat(12)4
Avg Revenue beat(12)-0.51%
Revenue beat(16)6
Avg Revenue beat(16)-0.27%
PT rev (1m)0.88%
PT rev (3m)8.63%
EPS NQ rev (1m)-0.58%
EPS NQ rev (3m)-11.25%
EPS NY rev (1m)1.39%
EPS NY rev (3m)1.35%
Revenue NQ rev (1m)-0.4%
Revenue NQ rev (3m)0.1%
Revenue NY rev (1m)-0.14%
Revenue NY rev (3m)-0.27%
Valuation
Industry RankSector Rank
PE 14.3
Fwd PE 12.76
P/S 1.23
P/FCF 22.91
P/OCF 12.62
P/B 1.47
P/tB 14.83
EV/EBITDA 10.53
EPS(TTM)3.41
EY6.99%
EPS(NY)3.82
Fwd EY7.84%
FCF(TTM)2.13
FCFY4.37%
OCF(TTM)3.87
OCFY7.93%
SpS39.68
BVpS33.06
TBVpS3.29
PEG (NY)0.95
PEG (5Y)N/A
Graham Number50.37
Profitability
Industry RankSector Rank
ROA 2.69%
ROE 6.14%
ROCE 6.63%
ROIC 3.26%
ROICexc 3.7%
ROICexgc 8.63%
OM 9.76%
PM (TTM) 5.11%
GM 24.99%
FCFM 5.37%
ROA(3y)0.52%
ROA(5y)1.33%
ROE(3y)2%
ROE(5y)5.13%
ROIC(3y)1.83%
ROIC(5y)2.61%
ROICexc(3y)1.84%
ROICexc(5y)2.65%
ROICexgc(3y)3.69%
ROICexgc(5y)5.83%
ROCE(3y)3.71%
ROCE(5y)5.33%
ROICexgc growth 3Y-17.75%
ROICexgc growth 5Y-15.4%
ROICexc growth 3Y-12.52%
ROICexc growth 5Y-11.09%
OM growth 3Y-9.84%
OM growth 5Y-8.98%
PM growth 3Y-23.64%
PM growth 5Y-16.51%
GM growth 3Y-3.58%
GM growth 5Y-3.36%
F-Score7
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 11.28
Debt/EBITDA 3.4
Cap/Depr 86.4%
Cap/Sales 4.38%
Interest Coverage 6.84
Cash Conversion 65.69%
Profit Quality 104.9%
Current Ratio 1.26
Quick Ratio 0.99
Altman-Z 2.07
F-Score7
WACC5.26%
ROIC/WACC0.62
Cap/Depr(3y)72.62%
Cap/Depr(5y)76.65%
Cap/Sales(3y)6.17%
Cap/Sales(5y)6.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)215.74%
EPS 3Y-2.62%
EPS 5Y-2.29%
EPS Q2Q%20.29%
EPS Next Y15%
EPS Next 2Y12.68%
EPS Next 3Y11.74%
EPS Next 5Y10.63%
Revenue 1Y (TTM)2.13%
Revenue growth 3Y-16.51%
Revenue growth 5Y-9.22%
Sales Q2Q%2.22%
Revenue Next Year4.48%
Revenue Next 2Y4.84%
Revenue Next 3Y4.86%
Revenue Next 5Y4.9%
EBIT growth 1Y51.21%
EBIT growth 3Y-24.73%
EBIT growth 5Y-17.37%
EBIT Next Year65.95%
EBIT Next 3Y24.42%
EBIT Next 5Y15.57%
FCF growth 1Y-61.64%
FCF growth 3Y-21.04%
FCF growth 5Y-3.73%
OCF growth 1Y-52.6%
OCF growth 3Y-21.94%
OCF growth 5Y-10.74%

FRESENIUS SE & CO KGAA / FRE.DE FAQ

What is the ChartMill fundamental rating of FRESENIUS SE & CO KGAA (FRE.DE) stock?

ChartMill assigns a fundamental rating of 4 / 10 to FRE.DE.


What is the valuation status of FRESENIUS SE & CO KGAA (FRE.DE) stock?

ChartMill assigns a valuation rating of 3 / 10 to FRESENIUS SE & CO KGAA (FRE.DE). This can be considered as Overvalued.


Can you provide the profitability details for FRESENIUS SE & CO KGAA?

FRESENIUS SE & CO KGAA (FRE.DE) has a profitability rating of 5 / 10.


Can you provide the financial health for FRE stock?

The financial health rating of FRESENIUS SE & CO KGAA (FRE.DE) is 4 / 10.


Can you provide the dividend sustainability for FRE stock?

The dividend rating of FRESENIUS SE & CO KGAA (FRE.DE) is 3 / 10 and the dividend payout ratio is 59.84%.